Bruce M Halpryn
Director Ejecutivo en Eikonoklastes Therapeutics, Inc. .
Perfil
Bruce M Halpryn is the founder of Myonexus Therapeutics, Inc. which was founded in 2017.
He held the title of Chief Operating Officer, Secretary & Director at Myonexus Therapeutics, Inc. from 2017 to 2024.
Dr. Halpryn is currently the Chairman & Chief Executive Officer at Eikonoklastes Therapeutics, Inc.
Cargos activos de Bruce M Halpryn
| Empresas | Cargo | Inicio |
|---|---|---|
Eikonoklastes Therapeutics, Inc.
 Eikonoklastes Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eikonoklastes Therapeutics, Inc. provides pharmaceutical services. It develops a state of the art immune conjugate technology targeting tissue factor for the treatment of solid tumors and other pathologic conditions. The company was founded by Zhiwei Hu and is headquartered in Cincinnati, OH. | Director Ejecutivo | - |
Antiguos cargos conocidos de Bruce M Halpryn.
| Empresas | Cargo | Fin |
|---|---|---|
Myonexus Therapeutics, Inc.
 Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Fundador | 01/04/2024 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Myonexus Therapeutics, Inc.
Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Health Technology |
Eikonoklastes Therapeutics, Inc.
Eikonoklastes Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eikonoklastes Therapeutics, Inc. provides pharmaceutical services. It develops a state of the art immune conjugate technology targeting tissue factor for the treatment of solid tumors and other pathologic conditions. The company was founded by Zhiwei Hu and is headquartered in Cincinnati, OH. | Health Technology |
- Bolsa de valores
- Insiders
- Bruce M Halpryn
